Cord Blood. Investieren in die Zukunft von Morgen.

 

wollt ihr die dinger so schnell los werden?
sind eure posis überhaupt noch genug wert damit sich das lohnt???? XD  

16. Juni 2011 Aktionäre Dearcord Blood Amerika, Inc., Ich schreibe, um zu bestätigen, dass wir fortfahren, alles in unserer Energie zu tun, dass die Aktionäre, in der Lage sind ihre Anteile zu handeln, auf die Art und Weise zu garantieren, die sie vorher konnten, so schnell wie möglich, der 21. April 2011-Aktionärabstimmung folgend, um die Rückauf lagerspalte zu genehmigen und der autorisierten Anteile des Stammkapitals der Firma sich zu erhöhen. Wir fahren fort, alles zu tun, das wenn sie, in einer prompten Weise benötigt wird, ersucht werden. Z.Z. erwarten wir noch Abstand durch Depository Trust Company („DTC "). Wir wissen, ob es eine bestimmte Ausgabe, die gibt ihren Prozess hält, und wenn ja, was diese Ausgabe ist, nicht trotz des unzähligen Ersuchens um eine Antwort auf denen und anderen Fragen. Zu sicher sein fast täglich zu lassen, versuchen wir, Kontakt mit dem DTC auf gewisse Weise das DTC sind geöffnet für Geschäft und manchmal mehrfache Zeiten pro Tag. Wir sind wir erhalten dieses gelöst überzeugt, aber leider, wissen Sie nicht wann. Wir erkennen die Frustration unserer Aktionäre. Weiter besteht unser Führungsteam aus Einzelpersonen, die Aktionäre sind. Wir fahren fort, in Richtung zu einer Entschließung zu drücken. Ich wiederhole von der vorhergehenden Korrespondenz, dass dieses eine Warteperiode ist, die wir nicht bevorzugen, und wenn es mehr gab, könnten wir tun, um es zum Schliessen zu holen, wir wurden. Herzlichst, Stephen Morgan Chefsyndikus Schnur-Blut Amerika, Inc.  

17.06.2011 11:03
(3 Leser)
1
2
3
4
5

(0 Bewertungen)
                    §
Schrift ändern:
PR Newswire · Mehr Nachrichten von PR Newswire · Archiv
Cord Blood America Acquires Assets of NeoCells, an Illinois Stem Cell Storage Company

LAS VEGAS, June 17, 2011 /PRNewswire/ -- Cord Blood America, Inc. (http://www.cordblood-america.com) (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, is pleased to announce that it has acquired the assets of NeoCells, a subsidiary of ViviCells International, Inc., Evanston, Illinois, through a foreclosure procedure at a purchase price of $320,000.

An excerpt from the filing states, "The Company proceeded .... to foreclose against all assets of NeoCells. At the public disposition of all property owned by NeoCells, the Company as a secured creditor bid $320,000 in offset debt, and acquired all right, title and interest in said property free and clear of any liens, security interests and encumbrances which are junior and subordinate to the Company''s security interest as a secured creditor."

"This is good news for our growth. CBAI has been highly acquisitive for a distinct reason. In today''s environment, with lots of companies struggling, we have found acquiring samples to be a very effective means to improve company gross margins," Mr. Schissler said.

"With this foreclosure, Cord Blood America has now added more than 2,700 customers this year through acquisition alone, not counting organic growth, including the previous purchase in February of all the umbilical cord blood samples from Reproductive Genetics Institute, Inc., also in Illinois," Mr. Schissler said. "All customers have had their umbilical cord blood stem cells, which were saved at birth, moved to our Las Vegas headquarters," said Matthew Schissler, co-founder and CEO. Â "We''ve assumed the cryogenic storage of these samples, and billings from their contracts. We are excited to welcome the NeoCells customers to the Cord Blood America family."

About Cord Blood America

Cord Blood America is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc., visit our website at http://www.corcell.com/. For investor information, visit http://www.cordblood-america.com/.

CONTACT:
Paul Knopick
E & E Communications
949/707-5365
pknopick@eandecommunications.com

SOURCE Cord Blood America, Inc.  

ein Illinois Stem Cell Storage Company

http://www.finanznachrichten.de/...-stem-cell-storage-company-008.htm

translate.google.de/translate

 

cord blood

http://gazette.jhu.edu/2011/06/20/...lect-stem-cells-from-cord-blood/

LAS VEGAS, am 28. Juni 2011/prnewswire/-Cord Blood America, Inc (www.cordblood-america.com) (OTC Anschlagbrett: CBAI), die Nabelschnur-Blutstammzelle-Bewahrungsgesellschaft konzentrierte sich darauf, das Lebenssparen-Potenzial von Stammzellen zu Familien landesweit und international zu bringen, gab heute bekannt, dass seine Stammaktien sind oder in Broker-Firmen von The Depository Trust & Clearing Corporation zurückgegeben worden sind. Das folgt einem Rückaktienspalt, der von mehr als 80 Prozent der Aktionäre genehmigt wurde, die ihre Vertretung dafür stimmen. "Wir freuen uns das wird aufgelöst," sagte Matthew Schissler, Mitbegründer und CEO.  

noch halten soll. Das Beste ist, daß in meinem Depot immer noch die alten Aktien liegen. D.h. ich kann den Scheiß noch nicht mal verramschen. Da hat uns Mr. Schissler so richtig angeschissen!!!  

beiße mir so in den arsch dass ich damals nich auf derpate und so gehört hab und die dinger abgestoßen hab :/
doch wieder nur eine blenderbude gewesen -_-  

vor dem R/S.
Hatte ein paar 100k Aktien.
Bei Genta habe ich mir die Finger verbrannt.
Hier bin ich schadlos entkommen.
Ich denke, unser eins wir gezielt durch optisch günstige Aktien zu einem Investment genötigt.
Leider habe ich damals vergessen folgendes zu kontrollieren:
- Anzahl der Aktien
Aktien x Kurs = Marktkapitalisierung!
Auf einmal relativiert sich der Kurs. Dann ist ein Unternehmen mit mehreren Nachkommastellen eine hoch-bewertetes Unternehmen.

- R/S
Hat es schonmal einen R/s gegeben?

So kann man die Buden sehr schnell entlarven. Ich investiere in Aktien dieser Couleur keinen Cent mehr.  

Alles nur Betrüger und Verbrecher.Irgendwann werden Sie Schissler lünchen.  

kannst du den text mal im original posten? die übersetzung ist echt mies....  

Cord Blood America Says Shares Being Returned to Brokerages  
 
[28-June-2011]  
 
LAS VEGAS, June 28, 2011 /PRNewswire/ -- Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, today announced that its common shares are being or have been returned to brokerage firms by The Depository Trust & Clearing Corporation.  This follows a reverse stock split which was approved by more than 80 percent of the shareholders voting their proxy. "We're glad this is resolved," said Matthew Schissler, co-founder and CEO.

About Cord Blood America

Cord Blood America is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc., visit our website at http://www.corcell.com/. For investor information, visit http://www.cordblood-america.com/.

Safe Harbor:  This press release contains forward-looking statements.   Forward-looking statements, which involve assumptions and describe our future plans, strategies and expectations, are generally identifiable by use of the words "may," "will," "should," "expect," "anticipate," "estimate," "believe," "intend" or "project" or the negative of these words or other variations on these words or comparable terminology. The reader is cautioned that such forward looking statements should not be construed as a guarantee or assurance of future performance or results. Actual events or results may differ materially from those discussed in forward-looking statements as a result of various factors.  In light of these risks and uncertainties, there can be no assurance that the forward-looking statements contained herein will in fact occur.   These forward-looking statements are based on current expectations, and the Company assumes no obligation to update this information. Readers are urged to carefully review and consider the various disclosures made by the Company in its Form 10-K and in the Company's other reports filed with the Securities and Exchange Commission that discuss certain of the risks and factors that may affect the Company and its business.

CONTACT:

Paul Knopick
E & E Communications
949/707-5365
pknopick@eandecommunications.com  

LAS VEGAS and NEWARK, N.J., June 29, 2011 /PRNewswire/ -- Cord Blood America, Inc. (http://www.cordblood-america.com) (OTC Bulletin Board:CBAI.ob - News), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, announced today it has entered into agreement with Horizon Healthcare Services, Inc., headquartered in Newark, New Jersey, to offer the storage of umbilical cord blood to its members. Under this agreement, members of Horizon Healthcare Services, Inc. will receive a discount on storage services compared to what Cord Blood America charges its other first-time customers.

"We are pleased that CorCell, our United States brand, can collaborate with Horizon Healthcare Services, Inc. and offer these important, potentially life-saving services, to its 3.6 million members.  We will also be offering courses to nurses and other healthcare professionals to help them counsel their patients on the value of stem cell storage," said Matthew Schissler, CEO and co-founder.

"We are focused on organic growth for CBAI.  Horizon Healthcare Services, Inc. is extremely important to us, and we look forward to educating the medical community and New Jersey families on  the regenerative importance of cord blood stem cells, while offering a discount because of our relationship," continued Mr. Schissler.

Cord blood stem cells are used today to treat more than 70 diseases including leukemia, severe anemia, metabolic blood disorders and immune deficiencies, while research is ongoing to determine the usefulness of stem cells in combating some of the nation's most serious diseases, including diabetes, heart disease, Parkinson's and other diseases for which there is currently no cure.

About Horizon Healthcare Services, Inc.

Horizon Healthcare Services, Inc., New Jersey's oldest and largest health insurer, is a not-for-profit health services corporation.  Horizon Healthcare Services, Inc. serves approximately 3.6 million members and is headquartered in Newark with offices in Wall, Mt. Laurel, and West Trenton.  Horizon Healthcare Services, Inc. provides a wide variety of medical, health and wellness, life insurance, worker compensation and dental insurance products and services, including Medicare and Medicaid products, for local and national businesses and individuals.  

mein depot ist immer noch nicht umgestellt...frechheit!  

wenn ich das richtig deute bedeutet das nur, dass die stammaktien von der dtcc wieder an die broker freigegeben wurden....
kann mich aber auch irren :D  

Es ist doch echt eine Frechheit,dass wir hier nicht handeln können.Ich würde zwar eh nicht verkaufen ,weil ich an dieses Konzept glaube. Wie kann es aber sein ,dass in Deutschland die Aktie gehandelt wird,ohne das sie freigegeben ist.?  

bislang waren ja auch erst minimale umsätze zu sehen  

wurde heute umgestellt.  

hat heute die stücke eingetragen. Split 100 zu 1  

Es wurde ja auch langsam mal Zeit das die Aktie umgestellt wird.Da ich eh schon im dunkelroten Bereich bin ,werde ich abwarten .Ich glaube dennoch an den Erfolg ,obwohl es derzeit sehr schwierig ist.

Euch allen wünsche ich einen schönen und sonnigen Tag.  

http://www.finanznachrichten.de/...s-referral-rewards-program-008.htm  

Last but not least (first, actually) is Cord Blood America Inc. ... the day's most favorite pick of all. This outfit does precisely what its name implies - it stores cord blood for potential later use as part of an individual's gene therapy. This blood has the 'right' DNA that can solve problems the body can't always solve naturally after the aging process takes its toll on the immune system.

In any case, CBAI shares are knocking on the door of new multi-year lows, though that's nothing new. The most recent line in the sand (floor) is $0.12, which also happens to be where the stock reached its most dire past low.... in 2008. If Cord Blood America happen to slide under long-term lows and on to levels not seen ever, even in the middle of the recession, that would pretty much drive a mental nail on the coffin for long-term holders. So, someone is clearly doing all they can to buoy CBAI here and now.

Quelle: http://www.smallcapnetwork.com/.../via/10/article/view/p/mid/3/id/18/  

hat hier jemand nen RT von advfn von cord?
Wäre lieb, wenn ihn dann jemand reinstellen würde.
LG Timo